Marine Andersson

About me
Publications
CV
Public outreach and news

About me

Farmaceut och doktor i medicinska vetenskaper vid avd. för klinisk
farmakolog, instutionen för Laboratoriemedicin. Huvudsakligen intresserad av
läkemedelsinteraktioner och arbetar med källorna Janusmed Interaktioner och
Riskprofil.

Research

Publikationer:
https://www.ncbi.nlm.nih.gov/pubmed/?term=andersson+marine

Teaching

Introduktion till R, doktorandkurs vid KI (2.5 hp)
http://kiwas.ki.se/katalog/katalog/kurs/2569

Articles

Article: PHARMACEUTICS. 2024;16(3):303

Drug–Drug Interactions in Patients with Acute Respiratory Distress Syndrome

Bischof T; Schaller C; Buchtele N; Staudinger T; Ullrich R; Kraft F; Andersson ML; Jilma B; Schoergenhofer C
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2023;79(9):1261-1269

Medicines postpartum in Sweden and coverage in Janusmed Breastfeeding.

Asplund AB; Sköld PD; Lind LK; Cesta CE; Dahl ML; Jonsson EW; Andersson ML
Article: DRUGS & AGING. 2023;40(4):369-376

Pharmacological Risk Assessment Among Older Patients with Polypharmacy Using the Clinical Decision Support System Janusmed Risk Profile: A Cross-Sectional Register Study.

Petersson L; Schörgenhofer C; Askfors Y; Justad H; Dahl M-L; Andersson ML
Article: PHARMACY. 2021;9(1):23

Patients' Use and Perceptions of a Drug-Drug Interaction Database: A Survey of Janusmed Interactions.

Justad H; Askfors Y; Shemeikka T; Andersson ML; Hammar T
Article: EXPERT REVIEW OF CLINICAL PHARMACOLOGY. 2020;13(9):925-934

Guiding principles for the use of knowledge bases and real-world data in clinical decision support systems: report by an international expert workshop at Karolinska Institutet.

Hoffmann M; Vander Stichele R; Bates DW; Björklund J; Alexander S; Andersson ML; Auraaen A; Bennie M; Dahl M-L; Eiermann B; Hackl W; Hammar T; Hjemdahl P; Koch S; Kunnamo I; Le Louët H; Panagiotis P; Rägo L; Spedding M; Seidling HM; Demner-Fushman D; Gustafsson LL
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2019;75(10):1387-1392

The effect of simvastatin on warfarin anticoagulation: a Swedish register-based nationwide cohort study.

Andersson ML; Mannheimer B; Lindh JD
Article: BMC GERIATRICS. 2019;19(1):164

Clinical relevance of alerts from a decision support system, PHARAO, for drug safety assessment in the older adults.

Hedna K; Andersson ML; Gyllensten H; Hägg S; Böttiger Y
Article: PLOS ONE. 2019;14(4):e0215356

Is tramadol associated to bleeding peptic ulcer? A nationwide case-control study in hospitalized Swedish patients.

Järnbert-Pettersson H; Andersson ML; Bilén K; Broström O; Lindh JD; Mannheimer B
Article: BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2018;122(5):512-516

High Prevalence of Drug-Drug Interactions in Primary Health Care is Caused by Prescriptions from other Healthcare Units.

Andersson ML; Böttiger Y; Kockum H; Eiermann B
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2018;74(3):365-371

Development and pilot testing of PHARAO-a decision support system for pharmacological risk assessment in the elderly.

Böttiger Y; Laine K; Korhonen T; Lähdesmäki J; Shemeikka T; Julander M; Edlert M; Andersson ML
Article: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2017;15(3):446-453

The effect of amiodarone on warfarin anticoagulation: a register-based nationwide cohort study involving the Swedish population.

Holm J; Lindh JD; Andersson ML; Mannheimer B
Article: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2016;14(4):765-771

The effect of carbamazepine on warfarin anticoagulation: a register-based nationwide cohort study involving the Swedish population.

Mannheimer B; Andersson ML; Järnbert-Pettersson H; Lindh JD
Article: INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS. 2015;84(5):327-333

Evaluation of usage patterns and user perception of the drug-drug interaction database SFINX.

Andersson ML; Böttiger Y; Bastholm-Rahmner P; Ovesjö M-L; Vég A; Eiermann B
Article: PLOS ONE. 2014;9(5):e97388

Adherence to guidelines for avoiding drug interactions associated with warfarin--a Nationwide Swedish Register Study.

Lindh JD; Andersson ML; Mannheimer B
Article: JOURNAL OF CLINICAL PHARMACOLOGY. 2013;53(12):1322-1327

The impact of interacting drugs on dispensed doses of warfarin in the Swedish population: A novel use of population based drug registers.

Andersson ML; Lindh JD; Mannheimer B
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2013;69 Suppl 1:65-72

The continuing challenge of providing drug information services to diminish the knowledge--practice gap in medical practice.

Alván G; Andersson ML; Asplund AB; Böttiger Y; Elwin C-E; Gustafsson LL; Öhman B; Törnqvist E
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2013;69(3):565-571

Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care.

Andersson ML; Böttiger Y; Lindh JD; Wettermark B; Eiermann B
Article: PHARMACOGENOMICS. 2012;13(7):757-762

A clinically significant interaction between warfarin and simvastatin is unique to carriers of the CYP2C9*3 allele.

Andersson ML; Eliasson E; Lindh JD
Article: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2011;72(1):153-156

Possible drug-drug interaction between quetiapine and lamotrigine--evidence from a Swedish TDM database.

Andersson ML; Björkhem-Bergman L; Lindh JD
Article: DRUG METABOLISM AND DISPOSITION. 2011;39(5):933-937

Seasonal variation in blood drug concentrations and a potential relationship to vitamin D.

Lindh JD; Andersson ML; Eliasson E; Björkhem-Bergman L
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2009;65(6):627-633

SFINX-a drug-drug interaction database designed for clinical decision support systems.

Böttiger Y; Laine K; Andersson ML; Korhonen T; Molin B; Ovesjö M-L; Tirkkonen T; Rane A; Gustafsson LL; Eiermann B
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2009;65(4):365-375

Influence of CYP2C9 genotype on warfarin dose requirements--a systematic review and meta-analysis.

Lindh JD; Holm L; Andersson ML; Rane A
Article: LAKARTIDNINGEN. 2006;103(14):1112-1114

[Citalopram is not safe from the cardiac point of view--SSRI preparations can cause prolonged QTc time].

Odar-Cederlöf I; Hjelmström P; Jersenius I; Andersson M; Rasmanis G; Bergman U
Show more

All other publications

Thesis / dissertation: 2014

Drug-drug interactions : from knowledge base to clinical impact

Andersson, Marine
Review: DRUGS. 2013;73(6):533-543

Cytochrome P450-mediated changes in oxycodone pharmacokinetics/pharmacodynamics and their clinical implications.

Söderberg Löfdal KC; Andersson ML; Gustafsson LL
Letter: PHARMACOGENOMICS. 2012;13(14):1561-1562

Influence of the CYP2C9*3 allele on the pharmacological interaction between warfarin and simvastatin: author reply

Andersson ML; Eliasson E; Lindh JD

Employments

Affiliated to Teaching/Tutoring, Department of Laboratory Medicine, Karolinska Institutet, 2023-2026

Degrees and Education

Degree Of Doctor Of Philosophy, Department of Laboratory Medicine, Karolinska Institutet, 2014

About me

Research

Teaching

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI